hgsi
Human Genome Sciences Inc. (NASDAQ: HGSI) is trading up exponentially on positive study data in serologically active systemic lupus. This is today's exponential price/volume alert stock with shares up some 200% north of $10.00. Human Genome Sciences Inc. (NASDAQ: HGSI) is not just trading higher on positive news. It is as if the company remapped the human genome like we saw back in the old days. It and GlaxoSmithKline (NYSE: GSK) have announced that the Human Genome Sciences Inc. (NASDAQ: HGSI) is going to be the top price leader this morning. It and GlaxoSmithKline (GSK) have announced that the BENLYSTA study met the primary endpoint in BLISS-52, the first of two pivotal Phase III